Vertex Pharmaceuticals Inc / Ma
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 62,522 | 0.1% | 137,909 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 58,099 | 0.1% | 148,349 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 63,636 | 0.2% | 142,938 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 74,021 | 0.2% | 152,677 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 61,307 | 0.2% | 152,240 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 71,706 | 0.2% | 154,179 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 69,958 | 0.2% | 149,254 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 67,702 | 0.2% | 161,962 | 3/31/2024 |
| 2023 Q4 | 2/12/2024 | 64,284 | 0.2% | 157,988 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 55,510 | 0.2% | 159,631 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 63,470 | 0.2% | 180,359 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 53,556 | 0.2% | 169,982 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 49,526 | 0.2% | 171,502 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 51,855 | 0.2% | 179,093 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 62,261 | 0.2% | 220,949 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 65,446 | 0.1% | 250,778 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 45,413 | 0.1% | 206,800 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 48,794 | 0.1% | 269,001 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 85,658 | 0.2% | 424,829 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 61,638 | 0.1% | 286,833 | 3/31/2021 |
| 2020 Q4 | 2/3/2021 | 83,557 | 0.2% | 353,546 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 95,460 | 0.2% | 350,800 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 104,248 | 0.3% | 359,091 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 49,799 | 0.2% | 209,282 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 53,915 | 0.1% | 246,245 | 12/31/2019 |
| 2014 Q1 | 5/14/2014 | 22,612 | 0.1% | 319,739 | 3/31/2014 |
| 2013 Q4 | 2/12/2014 | 25,715 | 0.1% | 346,099 | 12/31/2013 |